Press Release

Pharma ADMET Testing Market 2017-2027

NEW YORK, July 31, 2017 /PRNewswire/ -- Report DetailsThe pharma ADMET testing market is estimated at $7.43bn in 2016 and is expected to grow at a CAGR of 12.32% in the first half of the forecast period. The market is expected to grow at a CAGR of 10.50% in the second half of the forecast period. In 2016, the largest sector of the market was in vitro testing, which accounted for 44.3% of the ADMET testing market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Pharma ADMET Testing market forecasts from 2017-2027

• This report also breaks down the revenue forecast for the main submarkets:- In Vivo ADMET Testing- In Vitro ADMET Testing- In Silico ADMET Testing

• This report provides individual revenue forecasts to 2027 for these regional and national markets:- The US- Japan- Germany- France- Italy- Spain- The UK- China- Brazil- Russia- India- South Korea- Rest of the World

• Our study includes SWOT and STEP analysis of this industry and market.

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her
physician.